The company committed an investment of ₹3,00,00,000 (Rupees Three Crore only) in Nippon India Credit Opportunities AIF Scheme II on November 04, 2026. This AIF is a SEBI-registered Alternative Investment Fund.
This investment action follows a previous intimation dated August 08, 2026, regarding the approval of the investment limit by the company's Investment Committee. The current commitment is within that previously approved limit.
The source of funding for this investment is internal accruals. The committed amount will be drawn down in tranches.
The company has confirmed that the AIF, its sponsor, and its manager are not related parties of Amwill Health Care Limited.
This disclosure is made in compliance with Regulation 30 of the SEBI Listing Regulations and will be available on the company's website at www.amwillhealthcare.com.
The document is signed by Anshu Anshuman, ACS 65515, who holds the position of Company Secretary and Compliance Officer. The place of signing is Bangalore.